General Counsel of $RVMD sells 1,799 shares in insider sale

Shares (-13.0%) from their portfolio in Q2 2025, for an estimated $56,221,852BAKER BROS. ADVISORS LP added 1,428,000 shares (+18.0%) to their portfolio in Q2 2025, for an estimated $52,536,120CITADEL ADVISORS LLC added 1,344,608 shares (+1010.5%) to their portfolio in Q2 2025, for an estimated $49,468,128BALYASNY ASSET MANAGEMENT L.P. removed 1,302,848 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $46,068,705To monitor hedge funds’ activity regarding stock portfolios, visit Quiver Quantitative’s institutional holdings dashboard.

Regarding analyst ratings, various firms have recently provided insights on $RVMD. In recent times, nine firms have issued buy ratings on the stock, with no sell ratings. Notable ratings include Goldman Sachs issuing a “Buy” rating on 09/12/2025, Needham issuing a “Buy” rating on 09/11/2025, Wells Fargo issuing an “Overweight” rating on 09/11/2025, Wedbush issuing an “Outperform” rating on 09/11/2025, Piper Sandler issuing an “Overweight” rating on 08/19/2025, Guggenheim issuing a “Buy” rating on 06/25/2025, and HC Wainwright & Co. issuing a “Buy” rating on 05/14/2025. To follow analyst ratings and price targets for $RVMD, refer to Quiver Quantitative’s $RVMD forecast page.

While considering price targets, 13 analysts have offered projections for $RVMD in the past six months, with a median target of $73.0. Notable recent targets include Andrea Newkirk from Goldman Sachs setting a target price of $73.0 on 09/12/2025, Sean McCutcheon from Raymond James setting a target price of $72.0 on 09/12/2025, Robert Driscoll from Wedbush setting a target price of $77.0 on 09/11/2025, Ami Fadia from Needham setting a target price of $66.0 on 09/11/2025, Eva Fortea Verdejo from Wells Fargo setting a target price of $70.0 on 09/11/2025, Asthika Goonewardene from Truist Securities setting a target price of $99.0 on 09/05/2025, and Kelsey Goodwin from Piper Sandler setting a target price of $75.0 on 08/19/2025.

This article does not constitute financial advice. Refer to Quiver Quantitative’s disclaimers for further information.